Adam Mendelsohn

Company: Vivani Medical

Job title: Chief Executive Officer

Seminars:

Advancing Chronic Disease Management with Ultra Long-Acting Miniature Subdermal Implants of GLP-1 4:20 pm

Exploring the NanoPortal™ implant technology, emphasizing its design for consistent drug delivery Insights on NPM-115 and NPM-119 and the LIBERATE-1 study evaluating the efficacy of the six-month exenatide implants for obesity and type 2 diabetes Exploration of the potential impact of ultra-long-acting implants on chronic disease management and advancements in alternative drug delivery methodsRead more

day: Conference Day One

Panel Discussion: The Obesity Race on the Manufacturing Floor – Exploring Supply Challenges with Innovations in Discovery 2:40 pm

Examining supply chain challenges associated with peptides, including raw material shortages and complex manufacturing processes, and how these impact the availability of GLP-1 drugs compared to other therapeutic classes Analyzing the disparity between the rapidly increasing demand for GLP-1 receptor agonists and the current manufacturing capacity, highlighting how this affects market supply and patient access…Read more

day: Conference Day One